{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:47:26Z","timestamp":1790938046678,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Limited literature exists regarding whether intraoperative analysis of frozen debulk specimens during Mohs micrographic surgery (MMS) improves identification of high-risk features (HRF) of cutaneous squamous cell carcinoma (CSCC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Primary: identification of new HRF on debulk specimens. Secondary: CSCC upstaged after considering debulk data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A single-center, retrospective cohort study of patients with biopsy-proven CSCC treated by MMS with intraoperative frozen debulk analysis. Restricted (poor differentiation, new perineural invasion \u22650.1 mm, and Breslow depth &gt;6 mm) and nonrestricted (any worsened tumor differentiation, any new perineural invasion, and Breslow depth &gt;2 mm) analyses were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>In restricted analysis, 3.94% of cases had 1 new HRF on debulk analysis. In nonrestricted analysis, 32.9% of cases had \u22651 new HRF; 7.6% increased by 2 HRF. Approximately 2.0% of cases were upstaged by American Joint Committee on Cancer system, eighth edition criteria, 1.4% by Brigham and Women's Hospital. Tumor size \u22652 cm, male sex, and moderate differentiation on biopsy were significantly associated with new HRF identified on debulk analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Intraoperative frozen debulk analysis can reveal HRF of CSCC not seen on biopsy or MMS stages, particularly among tumors \u22652 cm. American Joint Committee on Cancer system, eighth edition T2 tumors were most likely to be upstaged. Identification of new HRF on debulk analysis can improve CSCC staging and may impact patient treatment and follow-up.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002932","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T11:18:13Z","timestamp":1614338293000},"page":"599-604","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Utility of Debulk Specimens During Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Bridget E.","family":"McIlwee","sequence":"first","affiliation":[{"name":"Division of Dermatology, Wexner Medical Center, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Y.","family":"Abidi","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Wexner Medical Center, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Ravi","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Carr","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Wexner Medical Center, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2017.08.058","article-title":"Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, international union against cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/DSS.0000000000001146","article-title":"Detection of high-risk histologic features and tumor upstaging of nonmelanoma skin cancers on debulk analysis: a quantitative systematic review","volume":"43","author":"Singh","year":"2017","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2006.02472.x","article-title":"Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips","volume":"49","author":"Quaedvlieg","year":"2006","journal-title":"Histopathology"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/DSS.0000000000001276","article-title":"Correlation between original biopsy pathology and Mohs intraoperative pathology","volume":"44","author":"Stiegel","year":"2018","journal-title":"Dermatol Surg"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2019.02.058","article-title":"Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: a prospective review","volume":"81","author":"Kyllo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1524-4725.2012.02507.x","article-title":"Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery","volume":"38","author":"Chuang","year":"2012","journal-title":"Dermatol Surg"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1524-4725.2010.01747.x","article-title":"Prevalence of underdiagnosed aggressive non-melanoma skin cancers treated with Mohs micrographic surgery","volume":"36","author":"Izikson","year":"2010","journal-title":"Dermatol Surg"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/DSS.0000000000001536","article-title":"Impact of Mohs micrographic surgery on tumor staging of cutaneous squamous cell carcinoma: a comparison of the 7th and 8th editions of the American Joint Committee on Cancer Guidelines","volume":"44","author":"Montuno","year":"2018","journal-title":"Dermatol Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/ijd.12867","article-title":"Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth-Hitchcock experience","volume":"54","author":"Knackstedt","year":"2015","journal-title":"Int J Dermatol"},{"key":"R18-20250731","first-page":"268","article-title":"Prognostic factors for metastasis in squamous cell carcinoma of the skin","volume":"28","author":"Cherpelis","year":"2002","journal-title":"Dermatol Surg"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaad.2007.03.021","article-title":"Reliability of the histopathologic diagnosis of keratinocyte carcinomas","volume":"57","author":"Jagdeo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:16:29Z","timestamp":1754000189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002932","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]}}}